Literature DB >> 17848510

Human cone photoreceptor dependence on RPE65 isomerase.

Samuel G Jacobson1, Tomas S Aleman, Artur V Cideciyan, Elise Heon, Marcin Golczak, William A Beltran, Alexander Sumaroka, Sharon B Schwartz, Alejandro J Roman, Elizabeth A M Windsor, James M Wilson, Gustavo D Aguirre, Edwin M Stone, Krzysztof Palczewski.   

Abstract

The visual (retinoid) cycle, the enzymatic pathway that regenerates chromophore after light absorption, is located primarily in the retinal pigment epithelium (RPE) and is essential for rod photoreceptor survival. Whether this pathway also is essential for cone photoreceptor survival is unknown, and there are no data from man or monkey to address this question. The visual cycle is naturally disrupted in humans with Leber congenital amaurosis (LCA), which is caused by mutations in RPE65, the gene that encodes the retinoid isomerase. We investigated such patients over a wide age range (3-52 years) for effects on the cone-rich human fovea. In vivo microscopy of the fovea showed that, even at the youngest ages, patients with RPE65-LCA exhibited cone photoreceptor loss. This loss was incomplete, however, and residual cone photoreceptor structure and function persisted for decades. Basic questions about localization of RPE65 and isomerase activity in the primate eye were addressed by examining normal macaque. RPE65 was definitively localized by immunocytochemistry to the central RPE and, by immunoblotting, appeared to concentrate in the central retina. The central retinal RPE layer also showed a 4-fold higher retinoid isomerase activity than more peripheral RPE. Early cone photoreceptor losses in RPE65-LCA suggest that robust RPE65-based visual chromophore production is important for cones; the residual retained cone structure and function support the speculation that alternative pathways are critical for cone photoreceptor survival.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17848510      PMCID: PMC1986623          DOI: 10.1073/pnas.0706367104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  58 in total

1.  Perceived and actual performance of daily tasks: relationship to visual function tests in individuals with retinitis pigmentosa.

Authors:  J P Szlyk; W Seiple; G A Fishman; K R Alexander; S Grover; C L Mahler
Journal:  Ophthalmology       Date:  2001-01       Impact factor: 12.079

Review 2.  The biochemistry of the visual cycle.

Authors:  R R Rando
Journal:  Chem Rev       Date:  2001-07       Impact factor: 60.622

Review 3.  Confronting complexity: the interlink of phototransduction and retinoid metabolism in the vertebrate retina.

Authors:  J K McBee; K Palczewski; W Baehr; D R Pepperberg
Journal:  Prog Retin Eye Res       Date:  2001-07       Impact factor: 21.198

4.  RPE65 is essential for the function of cone photoreceptors in NRL-deficient mice.

Authors:  Andreas Wenzel; Johannes von Lintig; Vitus Oberhauser; Naoyuki Tanimoto; Christian Grimm; Mathias W Seeliger
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-02       Impact factor: 4.799

5.  A frameshift mutation in RPGR exon ORF15 causes photoreceptor degeneration and inner retina remodeling in a model of X-linked retinitis pigmentosa.

Authors:  William A Beltran; Pamela Hammond; Gregory M Acland; Gustavo D Aguirre
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-04       Impact factor: 4.799

Review 6.  Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents.

Authors:  Gabriel H Travis; Marcin Golczak; Alexander R Moise; Krzysztof Palczewski
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

7.  Mutation analysis of 3 genes in patients with Leber congenital amaurosis.

Authors:  A J Lotery; P Namperumalsamy; S G Jacobson; R G Weleber; G A Fishman; M A Musarella; C S Hoyt; E Héon; A Levin; J Jan; B Lam; R E Carr; A Franklin; S Radha; J L Andorf; V C Sheffield; E M Stone
Journal:  Arch Ophthalmol       Date:  2000-04

8.  Differential macular and peripheral expression of bestrophin in human eyes and its implication for best disease.

Authors:  Robert F Mullins; Markus H Kuehn; Elizabeth A Faidley; Nasreen A Syed; Edwin M Stone
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-07       Impact factor: 4.799

9.  Reduced-illuminance autofluorescence imaging in ABCA4-associated retinal degenerations.

Authors:  Artur V Cideciyan; Malgorzata Swider; Tomas S Aleman; Marisa I Roman; Alexander Sumaroka; Sharon B Schwartz; Edwin M Stone; Samuel G Jacobson
Journal:  J Opt Soc Am A Opt Image Sci Vis       Date:  2007-05       Impact factor: 2.129

10.  Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation.

Authors:  Geoffrey K Aguirre; András M Komáromy; Artur V Cideciyan; David H Brainard; Tomas S Aleman; Alejandro J Roman; Brian B Avants; James C Gee; Marc Korczykowski; William W Hauswirth; Gregory M Acland; Gustavo D Aguirre; Samuel G Jacobson
Journal:  PLoS Med       Date:  2007-06       Impact factor: 11.069

View more
  83 in total

1.  Gene therapy for retinitis pigmentosa caused by MFRP mutations: human phenotype and preliminary proof of concept.

Authors:  Astra Dinculescu; Jackie Estreicher; Juan C Zenteno; Tomas S Aleman; Sharon B Schwartz; Wei Chieh Huang; Alejandro J Roman; Alexander Sumaroka; Qiuhong Li; Wen-Tao Deng; Seok-Hong Min; Vince A Chiodo; Andy Neeley; Xuan Liu; Xinhua Shu; Margarita Matias-Florentino; Beatriz Buentello-Volante; Sanford L Boye; Artur V Cideciyan; William W Hauswirth; Samuel G Jacobson
Journal:  Hum Gene Ther       Date:  2012-01-26       Impact factor: 5.695

2.  Histopathology and functional correlations in a patient with a mutation in RPE65, the gene for retinol isomerase.

Authors:  Vera L Bonilha; Mary E Rayborn; Yong Li; Gregory H Grossman; Eliot L Berson; Joe G Hollyfield
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-28       Impact factor: 4.799

Review 3.  Retinoids for treatment of retinal diseases.

Authors:  Krzysztof Palczewski
Journal:  Trends Pharmacol Sci       Date:  2010-06       Impact factor: 14.819

4.  Spectral domain optical coherence tomography and adaptive optics: imaging photoreceptor layer morphology to interpret preclinical phenotypes.

Authors:  Jungtae Rha; Adam M Dubis; Melissa Wagner-Schuman; Diane M Tait; Pooja Godara; Brett Schroeder; Kimberly Stepien; Joseph Carroll
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

5.  Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiency.

Authors:  J Pang; S E Boye; B Lei; S L Boye; D Everhart; R Ryals; Y Umino; B Rohrer; J Alexander; J Li; X Dai; Q Li; B Chang; R Barlow; W W Hauswirth
Journal:  Gene Ther       Date:  2010-03-18       Impact factor: 5.250

Review 6.  The retinal pigment epithelium in health and disease.

Authors:  J R Sparrow; D Hicks; C P Hamel
Journal:  Curr Mol Med       Date:  2010-12       Impact factor: 2.222

7.  Chemical chaperone TUDCA preserves cone photoreceptors in a mouse model of Leber congenital amaurosis.

Authors:  Tao Zhang; Wolfgang Baehr; Yingbin Fu
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-05       Impact factor: 4.799

8.  Inhibition of the visual cycle by A2E through direct interaction with RPE65 and implications in Stargardt disease.

Authors:  Gennadiy Moiseyev; Olga Nikolaeva; Ying Chen; Krysten Farjo; Yusuke Takahashi; Jian-xing Ma
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

9.  Scaffolds and stem cells: delivery of cell transplants for retinal degenerations.

Authors:  Karl E Kador; Jeffrey L Goldberg
Journal:  Expert Rev Ophthalmol       Date:  2012-10-01

Review 10.  Structural biology of 11-cis-retinaldehyde production in the classical visual cycle.

Authors:  Anahita Daruwalla; Elliot H Choi; Krzysztof Palczewski; Philip D Kiser
Journal:  Biochem J       Date:  2018-10-22       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.